Monash Medical Centre

Melbourne 3168

0 studies enrolling now · 3 studies all time

What they study most

Chronic Hepatitis C, Molybdenum Cofactor Deficiency, Molybdenum Cofactor Deficiency, Type A

Studies at this site

• Safety & Efficacy Study of ORGN001 (Formerly ALXN1101) in Pediatric Patients With MoCD Type A Currently Treated With rcPMP — Completed
• A Retrospective, Observational, Noninterventional Data Collection Study for Patients With Molybdenum Cofactor Deficiency Who Have Been Previously Treated With Cyclic Pyranopterin Monophosphate (cPMP) — Completed
• Sofosbuvir + Ribavirin for 12 Weeks in Subjects With Chronic Genotype 2 or 3 Hepatitis C Infection Who Are Interferon Intolerant, Interferon Ineligible or Unwilling to Take Interferon — Completed